Clinical trial
A Phase 1 Study to Assess the Pharmacokinetics and Safety of Ascending Doses of JOTROL Oral Gelcaps in Healthy Subjects, and to Determine the Influence of Food
NCT04668274 is registered in ClinicalTrials.gov with Jupiter Orphan Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study to Assess the Pharmacokinetics and Safety of Ascending Doses of JOTROL Oral Gelcaps in Healthy Subjects, and to Determine the Influence of Food
- Lead sponsor
- Jupiter Orphan Therapeutics Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 21, 2021
- Completion date
- May 31, 2021
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
food-drug interaction, pharmacokinetics, safety